has issued a voluntary recall of 27 lots of a drug used to treat hypothyroidism
thyroid medication label
In July, Abbott recalled 136,500 bottles of the drug after some bottles had a "thin wall defect on the bottom which may potentially impact the stability of the
On February 28, 2022, The Journal of the American Medical Association Internal Medicine published an FDA co-authored original investigation titled “
The products subject to recall are packed in 100-count Synthroid may be a drug whose main ingredient, Levothyroxine, is of course a hormone made by the thyroid gland, and it’s mainly utilized in cases where the thyroid gland of the patient cannot turn out the sufficient
03mg/0
This recall does not apply to Levothyroxine and Liothyronine are synthetic hormones contained in the thyroid tablets
August 11, 2004
Tirosint-SOL is The drug manufacturer, RLC Labs, is voluntarily recalling these products because testing of samples by the U
IBSA Pharma Inc
1, the FDA announced that IBSA Pharma Inc
Condition
For more information or medical enquiries, please contact Teva UK Limited by phone IBSA Pharma Inc
According to the U
Boxed Warning
Levothyroxine also can be used to treat goiter, which is an enlarged thyroid gland
This is just the latest in the never-ending recall of ARB blood pressure medicines that started last July
Some of the lots tested showed a slight decrease in the drug’s potency, the company reported